Jin said:
MaNoMaNoM said:
A research paper says that bufotenine levels in urine are (up to 34 w g/L).
PrimalSoup is recreating the experiment now, and will be bio-testing soon.
:want:wondering what tripping on myself is like?!
extracting bufo from urine sounds like a good idea , what does upto 34 w g/l really mean ? , how many active doses in a litre ?
and this is without consuming any psychedelic substance right ?
are we talking about nexus member Primal soup?
Primal soup from the shroomery.. Yes no mushrooms eaten.. i find human bufo very interesting !
but 34grams per liter seems like way to much tobe true.. Bufotenine active dose 5-100mg.~Ott
Here is the research papers being referenced...
Quote:
Abstract
Active compounds of some mushrooms e.g. Psilocybe cubensis, Paneolus subalteatus or Stropharia coronilla, the psychotropic agents psilocybin and psilocin, have hallucinogenic effects. In one case of ‘magic mushroom’ intake, we had to analyse blood and urine. Psilocin was detected in the urine with REMEDi HS. Most of the psilocin was excreted as the glucuronide. Therefore an enzymatic hydrolysis should be the first step in analysis. Free psilocin was determined at a concentration of 0.23 mg/l while the total amount was 1.76 mg/l urine. The concentration of psilocin in serum was too low for detection with REMEDi HS. We proved a GC–MS-method with d3-morphine as internal standard and silylation with MSTFA. Similarly to urine, most of the psilocin in serum was found in the conjugated form. The concentration of free psilocin was 0.018 mg/l, that of total psilocin, 0.052 mg/l serum.
Quote:
Research Article
Determination of potentially hallucinogenic N-dimethylated indoleamines in human urine by HPLC/ESI-MS-MS
2001, Vol. 61, No. 7 , Pages 547-556 (doi:10.1080/003655101753218319)
PDF (197 KB)
PDF Plus (198 KB)
Reprints
Permissions
T. Forsström, J. Tuominen, J. Kärkkäinen
A new method for the determination of N,N-dimethyl-5-hydroxytryptamine (bufotenine), N,N-dimethyltryptamine (DMT)*, 5-methoxy-N,N-dimethyltryptamine (5-MeODMT), and N-methyltryptamine (NMT) was developed using highperformance liquid chromatography-mass spectrometry (HPLC-MS). Identification of the analytes is based on liquid chromatographic retention times of analytes and two fragment ions produced by a triple quadrupole mass spectrometer. Quantification is based on electrospray ionization (ESI), and multiple reaction monitoring (MRM) was also utilized for getting better selectivity. The analytes and internal standard were separated from the urine matrix by solid-phase extraction (SPE). The method was applied for the determination of these compounds in urine samples of patients from surgical, medical and psychiatric wards. Of the dimethylated amines, only bufotenine was found in significant amounts (up to 34 w g/L). In keeping with our earlier results, the bufotenine excretion of psychiatric patients was found to be higher than that of the somatic patients. Method, procedure, considerations, statistical evaluations and urine sample spectra are presented.